SFINX interaction database
SFINX (Swedish, Finnish, INteraction X-referencing) is a drug-drug interaction database containing short, concise and validated information concerning consequences of and recommendations for more than 12.000 interaction pairs. The database can be integrated in a medical journal system, or be accessible through the Internet, and can thus readily facilitate the process of safe drug prescribing for the individual patient, as the clinician will be guided to choose the most appropriate action to handle specific drug interactions.
Copyright of the database belongs to medbase Ltd in Turku, Finland, the Karolinska Institute Department of Clinical Pharmacology in Stockholm, Sweden, and the Division of Drug Management and Informatics at Stockholm County Council, Sweden.
 
Content
SFINX contains information about relevant pharmacokinetic interactions that can be supported by scientific literature or by clinical studies referred to in drug SPCs (Summary of the Product Characteristics), and furthermore some clinically important pharmacokinetic interactions, that can be foreseen on the basis of known metabolic pathways. Documented pharmacodynamic interactions are also included, unless they are apparent from the main pharmacological action of the substances, as with e.g. agonists/antagonists to the same receptor.
Interaction texts are based on substance names and, whenever relevant, substance formulations. They are classified according to clinical significance (A-D) and documentation level (0-4), which enables threshold settings for automated warnings. All contents of the database are developed in accordance with documented standard operating procedures.
 
Technical solutions
Various literature sources are searched for information concerning drug interactions according to a standard operation procedure protocol. The information is evaluated and interaction texts are written in English and divided into five different parts: medical consequence, recommendation, mechanism, background and references. Medical consequence and recommendation parts are translated into various languages. All references are, whenever possible, linked to their source, e.g. PubMed abstracts.
The texts are written by health care professionals (e.g. physicians or pharmacists) and approved by specialists in clinical pharmacology.
Different terms can be used to connect the database to the local drug registry: substance name, CAS number, ATC code, NPLID, registry number of Sweden. A separate list for connection of drug formulations to the terms used in the database is available.
 
SFINX is an SQL database, which is updated four times a year and delivered to our customers as an XML-format export file.
 
 
Printer friendly version
Frontpage What is SFINX Contact us Links - Clients Login [staff only pages] Suomeksi Ruotsiksi